跳至主要内容
临床试验/DRKS00026631
DRKS00026631已完成未知

DiGA Cara Care für Reizdarm - Evaluation of a non-invasive, non-additionally burdensome, prospective, multicentered, two-armed, randomized trial with parallel group design

HiDoc Technologies GmbH0 个研究点目标入组 378 人开始时间: 2021年10月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
378

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • ? Medically confirmed diagnosis according to ICD-10-GM (K58.- i.e.: K58.1, K58.2, K58.3, K58.8).
  • ? signed Informed Consent Form.
  • ? Access to tablet/smartphone with internet access.
  • ? Willingness to use DiGA Cara Care for IBS on a regular, independent basis for at least 12 weeks.
  • ? Willingness to answer questions at four time points over a minimum of 12 weeks.

排除标准

  • Age < 18 years as well as > 70 years
  • Addiction or other illness, including mental illness (e.g., dementia, i.e., F00-F07), which may not enable patients to assess the nature and scope as well as possible consequences of participation in the study
  • Insufficient knowledge of the German language which is necessary to participate in the trial
  • Past use of DiGA Cara Care for irritable bowel syndrome for a period of more than 2 weeks

研究者

相似试验

DiGA Cara Care für Reizdarm - Evaluation of a... | 临床试验